1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Guo M, Zhao YD, Yang HJ and Yan XF:
Analysis of clinicopathological characteristics for 5406 cases of
esophageal neoplasm. Chin J Cancer Prev Treat. 15:54–56. 2008.
|
3
|
Debevec L, Jerič T, Kovač V, Bitenc M and
Sok M: Is there any progress in routine management of lung cancer
patients? A comparative analysis of an institution in 1996 and
2006. Radiol Oncol. 43:47–53. 2009. View Article : Google Scholar
|
4
|
Kovac V, Zwitter M and Zagar T: Improved
survival after introduction of chemotherapy for malignant pleural
mesothelioma in Slovenia: Population-based survey of 444 patients.
Radiol Oncol. 46:136–144. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Shi HY, Zhu SC, Shen WB and Liu ML:
Pathological characteristics of esophageal cancer. Oncol Lett.
8:533–538. 2014.PubMed/NCBI
|
6
|
Magni M, Shammah S, Schiró R, Mellado W,
Dalla-Favera R and Gianni AM: Induction of
cyclophosphamide-resistance by aldehyde-dehydrogenase gene
transfer. Blood. 87:1097–1103. 1996.PubMed/NCBI
|
7
|
Sophos NA and Vasiliou V: Aldehyde
dehydrogenase gene superfamily: The 2002 update. Chem Biol
Interact. 143–144:5–22. 2003. View Article : Google Scholar
|
8
|
Dylla SJ, Beviglia L, Park IK, Chartier C,
Raval J, Ngan L, Pickell K, Aguilar J, Lazetic S, Smith-Berdan S,
et al: Colorectal cancer stem cells are enriched in xenogeneic
tumors following chemotherapy. PLoS One. 3:e24282008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Chute JP, Muramoto GG, Whitesides J,
Colvin M, Safi R, Chao NJ and McDonnell DP: Inhibition of aldehyde
dehydrogenase and retinoid signaling induces the expansion of human
hematopoietic stem cells. Proc Natl Acad Sci USA. 103:11707–11712.
2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Armstrong L, Stojkovic M, Dimmick I, Ahmad
S, Stojkovic P, Hole N and Lako M: Phenotypic characterization of
murine primitive hematopoietic progenitor cells isolated on basis
of aldehyde dehydrogenase activity. Stem Cells. 22:1142–1151. 2004.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Hess DA, Wirthlin L, Craft TP, Herrbrich
PE, Hohm SA, Lahey R, Eades WC, Creer MH and Nolta JA: Selection
based on CD133 and high aldehyde dehydrogenase activity isolates
long-term reconstituting human hematopoietic stem cells. Blood.
107:2162–2169. 2006. View Article : Google Scholar : PubMed/NCBI
|
12
|
Nogami T, Shien T, Tanaka T, Nishiyama K,
Mizoo T, Iwamto T, Ikeda H, Taira N, Doihara H and Miyoshi S:
Expression of ALDH1 in axillary lymph node metastases is a
prognostic factor of poor clinical outcome in breast cancer
patients with 1–3 lymph node metastases. Breast Cancer. 21:58–65.
2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Patel M, Lu L, Zander DS, Sreerama L, Coco
D and Moreb JS: ALDH1A1 and ALDH3A1b expression in lung cancers:
Correlation with histologic type and potential precursors. Lung
Cancer. 59:340–349. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Zhou F, Mu YD, Liang J, Liu ZX, Chen HS
and Zhang JF: Expression and prognostic values of tumor stem cell
markers ALDH1 and CD133 in colorectal carcinoma. Oncol Lett.
7:507–512. 2014.PubMed/NCBI
|
15
|
Grimason AM, Smith HV, Parker JFW, Bukhari
Z, Campbell AT and Robertson LJ: Application of DAPI and
immunofluorescence for enhanced identification of
Cryptosporidium spp oocysts in water samples. Water Res.
28:733–736. 1994. View Article : Google Scholar
|
16
|
Leiker M, Suzuki G, Iyer VS, Canty JM Jr
and Lee T: Assessment of a nuclear affinity labeling method for
tracking implanted mesenchymal stem cells. Cell Transplant.
17:911–922. 2008. View Article : Google Scholar
|
17
|
Ocarino NM, Bozzi A, Pereira RD, Breyner
NM, Silva VL, Castanheira P, Goes AM and Serakides R: Behavior of
mesenchymal stem cells stained with 4′, 6-diamidino-2-phenylindole
dihydrochloride (DAPI) in osteogenic and non osteogenic cultures.
Biocell. 32:175–183. 2008.PubMed/NCBI
|
18
|
Van Vlierberghe RL, Sandel MH, Prins FA,
van Iersel LB, van de Velde CJ, Tollenaar RA and Kuppen PJ:
Four-color staining combining fluorescence and brightfield
microscopy for simultaneous immune cell phenotyping and
localization in tumor tissue sections. Microsc Res Tech. 67:15–21.
2005. View Article : Google Scholar : PubMed/NCBI
|
19
|
Huang EH, Hynes MJ, Zhang T, Ginestier C,
Dontu G, Appelman H, Fields JZ, Wicha MS and Boman BM: Aldehyde
dehydrogenase 1 is a marker for normal and malignant human colonic
stem cells (SC) and tracks SC overpopulation during colon
tumorigenesis. Cancer Res. 69:3382–3389. 2009. View Article : Google Scholar : PubMed/NCBI
|
20
|
National Comprehensive Cancer Network.
(NCCN) clinical practice guidelines in oncology. Esophageal and
esophagogastric junction cancers. Version 2. 2017.
|
21
|
Xu Y, Chen Q, Yu X, Zhou X, Zheng X and
Mao W: Factors influencing the risk of recurrence in patients with
esophageal carcinoma treated with surgery: A single institution
analysis consisting of 1002 cases. Oncol Lett. 5:185–190.
2013.PubMed/NCBI
|
22
|
Rubenstein JH and Chen JW: Epidemiology of
gastroesophageal reflux disease. Gastroenterol Clin North Am.
43:1–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Li S, Jiang S, Jiang W, Zhou Y, Shen XY,
Luo T, Kong LP and Wang HQ: Anticancer effects of crocetin in human
esophageal squamous cell carcinoma KYSE-150 cells. Oncol Lett.
9:1254–1260. 2015.PubMed/NCBI
|
24
|
Boman BM and Wicha MS: Cancer stem cells:
A step toward the cure. J Clin Oncol. 26:2795–2799. 2008.
View Article : Google Scholar : PubMed/NCBI
|